FCMI
Foresite Capital Management III Portfolio holdings
AUM
$37.9M
This Quarter Return
+60.51%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$112M
AUM Growth
+$112M
(+79%)
Cap. Flow
+$22.1M
Cap. Flow
% of AUM
19.69%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
3
Reduced
–
Closed
3
Top Buys
| 1 |
Oric Pharmaceuticals
ORIC
|
$16.8M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$6.22M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$5.58M |
| 4 |
EPZM
Epizyme, Inc
EPZM
|
$4.57M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$1.34M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$5.39M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$4.81M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$2.12M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYOK
1
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $38.6M | 34.31% | 399,360 +13,908 | +4% | +$1.34M |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $19.5M | 17.31% | 249,598 +79,698 | +47% | +$6.22M |
|
|
3
Oric Pharmaceuticals
ORIC
$994M
| $16.8M | 14.9% | +496,893 | New | +$16.8M |
|
|
EPZM
4
DELISTED
Epizyme, Inc
EPZM
| $16M | 14.26% | 998,278 +284,466 | +40% | +$4.57M |
|
5
Natera
NTRA
$23.1B
| $10.4M | 9.26% | 208,768 | – | – |
|
|
CBAY
6
DELISTED
Cymabay Therapeutics
CBAY
| $5.58M | 4.97% | +1,599,958 | New | +$5.58M |
|
|
XLRN
7
DELISTED
Acceleron Pharma Inc.
XLRN
| $4M | 3.56% | 42,030 | – | – |
|
8
FibroGen
FGEN
$47.8M
| $1.62M | 1.44% | 40,000 | – | – |
|
|
AERI
9
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| – | – | -356,492 | Closed | -$4.81M |
|
|
IMMU
10
DELISTED
Immunomedics Inc
IMMU
| – | – | -400,000 | Closed | -$5.39M |
|
|
BHVN
11
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – | -62,245 | Closed | -$2.12M |
|